Showing results (1-10 of 375) with videos related to
Sort By:
Pageof 38
Canadian Liver Journal|August 22, 2022
Contextualizing Canada's hepatitis C virus epidemicMel Krajden, Darrel Cook, Naveed Z JanjuaHepatology (Baltimore, Md.)|February 4, 2015
Differentiation of acute from chronic hepatitis C virus infection by nonstructural 5B deep sequencing: a population-level tool for incidence estimationVincent Montoya, Andrea D Olmstead, Naveed Z Janjua, et al.The Open AIDS Journal|April 6, 2011
Detection of Early Sero-Conversion HIV Infection Using the INSTI HIV-1 Antibody Point-of-Care TestDarrel Cook, Mark Gilbert, Lillo Difrancesco, et al.American Journal of Public Health|June 13, 2015
Decreasing Hepatitis C Incidence Among a Population With Repeated Tests: British Columbia, Canada, 1993-2011Margot Kuo, Naveed Z Janjua, Ann N Burchell, et al.Ebiomedicine|September 7, 2016
The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC)Naveed Z Janjua, Margot Kuo, Amanda Yu, et al.The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|April 18, 2019
Medical Information Commons to Support Learning Healthcare Systems: Examples From CanadaTania Bubela, Shelagh K Genuis, Naveed Z Janjua, et al.Journal of Viral Hepatitis|July 27, 2018
Estimating the impact of early hepatitis C virus clearance on hepatocellular carcinoma riskMaryam Darvishian, Naveed Z Janjua, Mei Chong, et al.Journal of Hepatology|November 8, 2016
Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in CanadaNaveed Z Janjua, Mei Chong, Margot Kuo, et al.CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 19, 2003
Impact of universal preadolescent vaccination against hepatitis B on antenatal seroprevalence of hepatitis B markers in British Columbia womenMeenakshi Dawar, David M Patrick, Mark Bigham, et al.Hepatology Communications|April 13, 2019
Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist TherapyNaveed Z Janjua, Maryam Darvishian, Stanley Wong, et al.Pageof 38